Role of lipid in forming an infectious prion?

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 6, 2013, Pages 485-493

  Wang, Fei ^a   Ma, Jiyan ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Lipid; Prion; Prion infectivity; Prion protein conversion; Recombinant prion

Indexed keywords

LIPID;

ANIMAL; CHEMISTRY; HUMAN; IONIZING RADIATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRION; PRION INFECTIVITY; PRION PROTEIN CONVERSION; PROTEIN CONFORMATION; RADIATION EXPOSURE; RECOMBINANT PRION; REVIEW; SCRAPIE; ULTRAVIOLET RADIATION;

LIPID; PRION; PRION INFECTIVITY; PRION PROTEIN CONVERSION; RECOMBINANT PRION;

ANIMALS; HUMANS; LIPIDS; PRIONS; PROTEIN CONFORMATION; RADIATION, IONIZING; SCRAPIE; ULTRAVIOLET RAYS;

EID: 84879213006     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt038     Document Type: Review

References (141)

1. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998, 95: 13363-13383.
2. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001, 24: 519-550.
3. Weissmann C. The state of the prion. Nat Rev Microbiol 2004, 2: 861-871.
4. Collinge J and Clarke AR. A general model of prion strains and their pathogenicity. Science 2007, 318: 930-936.
5. Aguzzi A, Baumann F and Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008, 31: 439-477.
6. Caughey B, Baron GS, Chesebro B and Jeffrey M. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 2009, 78: 177-204.
7. Gibbons RA and Hunter GD. Nature of the scrapie agent. Nature 1967, 215: 1041-1043.
8. Millson GC, Hunter GD and Kimberlin RH. The physico-chemical nature of the scrapie agent. Front Biol 1976, 44: 243-266.
9. Prusiner SB. Scrapie prions. Ann Rev Microbiol 1989, 43: 345-374.
10. Weissmann CA. 'Unified theory' of prion propagation. Nature 1991, 352: 679-683.
11. Brown P and Bradley R. 1755 and all that: a historical primer of transmissible spongiform encephalopathy. BMJ 1998, 317: 1688-1692.
12. Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 2000, 159: 10-17.
13. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216: 136-144.
14. Prusiner SB. Molecular biology of prion diseases. Science 1991, 252: 1515-1522.
15. Weissmann C. Spongiform encephalopathies. The prion's progress. Nature 1991, 349: 569-571.
16. Weissmann C. Molecular biology of prion disease. Trends in Cell Biol 1994, 4: 10.
17. Weissmann C and Flechsig E. PrP knock-out and PrP transgenic mice in prion research. Br Med Bull 2003, 66: 43-60.
18. Aguzzi A and Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 2004, 116: 313-327.
19. Hill AF and Collinge J. Prion strains and species barriers. Contrib Microbiol 2004, 11: 33-49.
20. Caughey B and Baron GS. Prions and their partners in crime. Nature 2006, 443: 803-810.
21. Soto C. Prion hypothesis: the end of the controversy? Trends Biochem Sci 2011, 36: 151-158.
22. Aguzzi A and Falsig J. Prion propagation, toxicity and degradation. Nat Neurosci 2012, 15: 936-939.
23. Cohen FE and Prusiner SB. Pathologic conformations of prion proteins. Annu Rev Biochem 1998, 67: 793-819.
24. Sigurdsson B. Rida, a chronic encephalitis of sheep. Br Vet J 1954, 110: 341-354.
25. Field EJ. Transmission experiments with multiple sclerosis: an interim report. Br Med J 1966, 2: 564-565.
26. Field EJ. The significance of astroglial hypertrophy in Scrapie, Kuru, Multiple Sclerosis and old age together with a note on the possible nature of the scrapie agent. Deutsche Zeitschrift für Nervenheilkunde 1967, 192: 265-274.
27. Pattison IH and Jones KM. The possible nature of the transmissible agent of scrapie. Vet Rec 1967, 80: 2-9.
28. Griffith JS. Self-replication and scrapie. Nature 1967, 215: 1043-1044.
29. Bessen RA and Marsh RF. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 1992, 66: 2096-2101.
30. Collinge J, Sidle KC, Meads J, Ironside J and Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD [see comments]. Nature 1996, 383: 685-690.
31. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R and Mastrianni J, et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996, 274: 2079-2082.
32. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M and Cohen FE, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998, 4: 1157-1165.
33. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ and Prusiner SB. Synthetic mammalian prions. Science 2004, 305: 673-676.
34. Jones EM and Surewicz WK. Fibril conformation as the basis of speciesand strain-dependent seeding specificity of mammalian prion amyloids. Cell 2005, 121: 63-72.
35. Castilla J, Saa P, Hetz C and Soto C. In vitro generation of infectious scrapie prions. Cell 2005, 121: 195-206.
36. Deleault NR, Harris BT, Rees JR and Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007, 104: 9741-9746.
37. Wang F, Wang X, Yuan CG and Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010, 327: 1132-1135.
38. Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R and Race B, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 2010, 285: 14083-14087.
39. Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H and Rohwer RG, et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 2010, 119: 177-187.
40. Wang F, Zhang Z, Wang X, Li J, Zha L, Yuan CG and Weissmann C, et al. Genetic informational RNA is not required for recombinant prion infectivity. J Virol 2012, 86: 1874-1876.
41. Deleault NR, Walsh DJ, Piro JR, Wang F, Wang X, Ma J and Rees JR, et al. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci USA 2012, 109: E1938-E1946.
42. Leopoldt JG. Nützliche und auf die Erfahrung Gegründete. In: Einleitung zu der landwirthschaft. Berlin: Christian Friedrich Günthern, 1759.
43. Besnoit C and Morel C. Note sur les le'sions nerveuses de la tremblante du mouton. Rev Vet 1898, 23: 397-400.
44. Besnoit C. La tremblante ou ne'vrite pe'riphe'rique enzootique du mouton. VI. Etiologie Rev Ve't 1899, 23: 307-343.
45. Curril J and Chelle PL. Is the disease of scrapie inoculable? Cr Hebd Acad Sci 1936, 203: 1552-1554.
46. Cuille J and Chelle PL. Experimental transmission of trembling to the goat. Cr Seances Acad Sci 1939, 208: 1058-1160.
47. Pattison IH, Gordon WS and Millson GC. Experimental production of scrapie in goats. J Comp Pathol 1959, 69: 300-312.
48. Cuille J and Chelle PL. Is the trembling of sheep detemined by a filtrable virus? Cr Hebd Acad Sci 1938, 206: 1687-1688.
49. Gordon WS. Advances in veterinary research-looping ill, tick-borne fever and scrapie. Vet Rec 1946, 58: 516-525.
50. Greig Jr. Scrapie in sheep. J Comp Pathol 1950, 60: 263-266.
51. Pattison IH. Resistance of the scrapie agent to formalin. J Comp Pathol 1959, 75: 159-164.
52. Stamp JT, Brotherston JG, Zlotnik I, Mackay JM and Smith W. Further studies on scrapie. J Comp Pathol 1959, 69: 268-280.
53. Pattison IH and Millson GC. Further experimental observations on scrapie. J Comp Pathol 1961, 71: 350-359.
54. Butler EJ and Smith W. An attempt to separate the scrapie agent from brain tissue. Vet Rec 1960, 72: 417-418.
55. Pattison IH and Millson GC. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Pathol 1961, 71: 101-109.
56. Pattison IH and Millson GC. Further observations on the experimental production of scrapie in goats and sheep. J Comp Pathol 1960, 70: 182-193.
57. Mould DL and Smith W. The causal agent of scrapie. I. Extraction of the agent from infected sheep tissue. J Comp Pathol 1962, 72: 97-105.
58. Hunter GD and Millson GC. Attempts to release the scrapie agent from tissue debris. J Comp Pathol 1967, 77: 301-307.
59. Alper T, Haig DA and Clarke MC. The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 1966, 22: 278-284.
60. Alper T, Cramp WA, Haig DA and Clarke MC. Does the agent of scrapie replicate without nucleic acid? Nature 1967, 214: 764-766.
61. Latarjet R, Muel B, Haig DA, Clarke MC and Alper T. Inactivation of the scrapie agent by near monochromatic ultraviolet light. Nature 1970, 227: 1341-1343.
62. Alper T, Haig DA and Clarke MC. The scrapie agent: evidence against its dependence for replication on intrinsic nucleic acid. J Gen Virol 1978, 41: 503-516.
63. Alper T. The scrapie enigma: insights from radiation experiments. Radiat Res 1993, 135: 283-292.
64. Mould DL and Smith W. The causal agent of scrapie. II. Extraction of the agent from infected goat tissue. J Comp Pathol 1962, 72: 106-112.
65. Hunter GD, Millson GC and Meek G. The intracellular location of the agent of mouse scrapie. J Gen Microbiol 1964, 34: 319-325.
66. Hunter GD and Millson GC. Studies on the heat stability and chromatographic behaviour of the scrapie agent. J Gen Microbiol 1964, 37: 251-258.
67. Mould DL, Smith W and Dawson AM. Centrifugation studies on the infectivities of cellular fractions derived from mouse brain infected with scrapie (Suffolk strain). J Gen Microbiol 1965, 40: 71-79.
68. Bolton DC, McKinley MP and Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982, 218: 1309-1311.
69. Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP and McKinley MP. Further purification and characterization of scrapie prions. Biochemistry 1982, 21: 6942-6950.
70. McKinley MP, Bolton DC and Prusiner SB. A protease-resistant protein is a structural component of the scrapie prion. Cell 1983, 35: 57-62.
71. Prusiner SB, Groth DF, Bolton DC, Kent SB and Hood LE. Purification and structural studies of a major scrapie prion protein. Cell 1984, 38: 127-134.
72. Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, Lechner D and Bergstrom S, et al. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 1985, 315: 331-333.
73. Oesch B, Westaway D, Walchli M, McKinley MP, Kent SB, Aebersold R and Barry RA, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985, 40: 735-746.
74. Basler K, Oesch B, Scott M, Westaway D, Wälchli M, Groth DF and McKinley MP, et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986, 46: 417-428.
75. Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA and Prusiner SB. Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci USA 1986, 83: 2310-2314.
76. Gabizon R, McKinley MP and Prusiner SB. Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci USA 1987, 84: 4017-4021.
77. Gabizon R, McKinley MP, Groth DF, Kenaga L and Prusiner SB. Properties of scrapie prion protein liposomes. J Biol Chem 1988, 263: 4950-4955.
78. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL and Prusiner SB. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 1993, 32: 1991-2002.
79. Klein TR, Kirsch D, Kaufmann R and Riesner D. Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry. Biol Chem 1998, 379: 655-666.
80. Leffers KW, Wille H, Stohr J, Junger E, Prusiner SB and Riesner D. Assembly of natural and recombinant prion protein into fibrils. Biol Chem 2005, 386: 569-580.
81. Baron GS, Magalhaes AC, Prado MA and Caughey B. Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsomeassociated versus purified PrP-res. J Virol 2006, 80: 2106-2117.
82. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF and Caughey WS. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991, 30: 7672-7680.
83. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D and Mehlhorn I, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993, 90: 10962-10966.
84. Gasset M, Baldwin MA, Fletterick RJ and Prusiner SB. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci USA 1993, 90: 1-5.
85. Smirnovas V, Baron GS, Offerdahl DK, Raymond GJ, Caughey B and Surewicz WK. Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat Struct Mol Biol 2011, 18: 504-506.
86. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT and Caughey B. Cell-free formation of protease-resistant prion protein. Nature 1994, 370: 471-474.
87. Kocisko DA, Priola SA, Raymond GJ, Chesebro B, Lansbury PT, Jr and Caughey B. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci USA 1995, 92: 3923-3927.
88. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT and Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995, 375: 698-700.
89. Mehlhorn I, Groth D, Stockel J, Moffat B, Reilly D, Yansura D and Willett WS, et al. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 1996, 35: 5528-5537.
90. Hornemann S, Korth C, Oesch B, Riek R, Wider G, Wuthrich K and Glockshuber R. Recombinant full-length murine prion protein, mPrP(23-231): purification and spectroscopic characterization. FEBS Lett 1997, 413: 277-281.
91. Riek R, Hornemann S, Wider G, Glockshuber R and Wuthrich K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 1997, 413: 282-288.
92. Zahn R, von Schroetter C and Wuthrich K. Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Lett 1997, 417: 400-404.
93. Hornemann S, Schorn C and Wuthrich K. NMR structure of the bovine prion protein isolated from healthy calf brains. EMBO Rep 2004, 5: 1159-1164.
94. Swietnicki W, Petersen R, Gambetti P and Surewicz WK. pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J Biol Chem 1997, 272: 27517-27520.
95. Baskakov IV, Legname G, Baldwin MA, Prusiner SB and Cohen FE. Pathway complexity of prion protein assembly into amyloid. J Biol Chem 2002, 277: 21140-21148.
96. Bocharova OV, Breydo L, Parfenov AS, Salnikov VV and Baskakov IV. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J Mol Biol 2005, 346: 645-659.
97. Colby DW, Wain R, Baskakov IV, Legname G, Palmer CG, Nguyen HO and Lemus A, et al. Protease-sensitive synthetic prions. PLoS Pathog 2010, 6: e1000736.
98. Caughey B, Neary K, Buller R, Ernst D, Perry LL, Chesebro B and Race RE. Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J Virol 1990, 64: 1093-1101.
99. Stahl N, Borchelt DR and Prusiner SB. Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositolspecific phospholipase C. Biochemistry 1990, 29: 5405-5412.
100. Borchelt DR, Scott M, Taraboulos A, Stahl N and Prusiner SB. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 1990, 110: 743-752.
101. Caughey B and Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipasesensitive. J Biol Chem 1991, 266: 18217-18223.
102. Caughey B, Raymond GJ, Ernst D and Race RE. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 1991, 65: 6597-6603.
103. Baron GS, Wehrly K, Dorward DW, Chesebro B and Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res [PrP(Sc)] into contiguous membranes. EMBO J 2002, 21: 1031-1040.
104. Baron GS and Caughey B. Effect of glycosylphosphatidylinositol anchordependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform. J Biol Chem 2003, 278: 14883-14892.
105. Morillas M, Swietnicki W, Gambetti P and Surewicz WK. Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem 1999, 274: 36859-36865.
106. Sanghera N and Pinheiro TJ. Binding of prion protein to lipid membranes and implications for prion conversion. J Mol Biol 2002, 315: 1241-1256.
107. Kazlauskaite J, Sanghera N, Sylvester I, Venien-Bryan C and Pinheiro TJ. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 2003, 42: 3295-3304.
108. Critchley P, Kazlauskaite J, Eason R and Pinheiro TJ. Binding of prion proteins to lipid membranes. Biochem Biophys Res Commun 2004, 313: 559-567.
109. Kazlauskaite J and Pinheiro TJ. Aggregation and fibrillization of prions in lipid membranes. Biochem Soc Symp 2005, 72: 211-222.
110. Wang F, Yang F, Hu Y, Wang X, Jin C and Ma J. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. Biochemistry 2007, 46: 7045-7053.
111. Wang X, Wang F, Arterburn L, Wollmann R and Ma J. The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity. J Biol Chem 2006, 281: 13559-13565.
112. Wang F, Yin S, Wang X, Zha L, Sy MS and Ma J. Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction. Biochemistry 2010, 49: 8169-8176.
113. Hill AF, Antoniou M and Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 1999, 80: 11-14.
114. Saborio GP, Permanne B and Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001, 411: 810-813.
115. Saa P, Castilla J and Soto C. Cyclic amplification of protein misfolding and aggregation. Methods Mol Biol 2005, 299: 53-65.
116. Castilla J, Saa P, Morales R, Abid K, Maundrell K and Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 2006, 412: 3-21.
117. Castilla J, Saa P and Soto C. Detection of prions in blood. Nat Med 2005, 11: 982-985.
118. Saa P, Castilla J and Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 2006, 281: 35245-35252.
119. Gonzalez-Romero D, Barria MA, Leon P, Morales R and Soto C. Detection of infectious prions in urine. FEBS Lett 2008, 582: 3161-3166.
120. Green KM, Castilla J, Seward TS, Napier DL, Jewell JE, Soto C and Telling GC. Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog 2008, 4: e1000139.
121. Castilla J, Gonzalez-Romero D, Saa P, Morales R, De Castro J and Soto C. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 2008, 134: 757-768.
122. Castilla J, Morales R, Saa P, Barria M, Gambetti P and Soto C. Cell-free propagation of prion strains. EMBO J 2008, 27: 2557-2566.
123. Wong C, Xiong LW, Horiuchi M, Raymond L, Wehrly K, Chesebro B and Caughey B. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J 2001, 20: 377-386.
124. Deleault NR, Lucassen RW and Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003, 425: 717-720.
125. Qin K, Yang DS, Yang Y, Chishti MA, Meng LJ, Kretzschmar HA and Yip CM, et al. Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidation. J Biol Chem 2000, 275: 19121-19131.
126. Quaglio E, Chiesa R and Harris DA. Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform. J Biol Chem 2001, 276: 11432-11438.
127. Basu S, Mohan ML, Luo X, Kundu B, Kong Q and Singh N. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis. Mol Biol Cell 2007, 18: 3302-3312.
128. Cordeiro Y, Machado F, Juliano L, Juliano MA, Brentani RR, Foguel D and Silva JL. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation. J Biol Chem 2001, 276: 49400-49409.
129. Adler V, Zeiler B, Kryukov V, Kascsak R, Rubenstein R and Grossman A. Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro. J Mol Biol 2003, 332: 47-57.
130. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA and Supattapone S. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 2005, 280: 26873-26879.
131. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF and Caughey B. The most infectious prion protein particles. Nature 2005, 437: 257-261.
132. Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC and Supattapone S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci USA 2012, 109: 8546-8551.
133. Piro JR, Harris BT and Supattapone S. In situ photodegradation of incorporated polyanion does not alter prion infectivity. PLoS Pathog 2011, 7: e1002001.
134. Wang F, Wang X and Ma J. Conversion of bacterially expressed recombinant prion protein. Methods 2011, 53: 208-213.
135. Ma J. The role of cofactors in prion propagation and infectivity. PLoS Pathog 2012, 8: e1002589.
136. Aguzzi A, Heikenwalder M and Polymenidou M. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 2007, 8: 552-561.
137. Aguzzi A. Unraveling prion strains with cell biology and organic chemistry. Proc Natl Acad Sci USA 2008, 105: 11-12.
138. Weissmann C. Thoughts on mammalian prion strains. Folia neuropathologica/Association of Polish Neuropathologists and Medical Research Centre. Polish Acad Sci 2009, 47: 104-113.
139. Li J, Browning S, Mahal SP, Oelschlegel AM and Weissmann C. Darwinian evolution of prions in cell culture. Science 2010, 327: 869-872.
140. Weissmann C, Li J, Mahal SP and Browning S. Prions on the move. EMBO Rep 2011, 12: 1109-1117.
141. Beringue V, Herzog L, Jaumain E, Reine F, Sibille P, Le Dur A, Vilotte JL and Laude H. Facilitated cross-species transmission of prions in extraneural tissue. Science 2012, 335: 472-475.